A Mutation Hot-Spot for Benign Infantile Epilepsy
J. Kearney
DOI: https://doi.org/10.5698/1535-7511-13.1.20
2013-01-01
Epilepsy Currents
Abstract:Commentary Three inherited paroxysmal neurologic disorders have all been mapped to the pericentromeric region of human chromosome 16. Paroxysmal kinesigenic dyskinesia, also known as episodic kinesigenic dyskinesia (EKD), is an adolescent-onset disorder characterized by brief, recurrent episodes of involuntary movement triggered by sudden voluntary movement (MIM128200). EKD1 was mapped to 16p11.2-q12.1 by linkage analysis in eight Japanese families (1), some of which were used for the current study by Ono and colleagues. Benign familial infantile seizures (BFIS) is characterized by infant-onset, afebrile seizures that remit by 2 years of age (MIM605751). BFIS2 was mapped to 16p12-q12 by linkage analysis in seven families (2). Co-occurrence of EKD and infantile seizures is referred to as infantile convulsions and choreoathetosis (ICCA) syndrome. Within the same family, individuals may have infantile seizures, EKD, or both (MIM 602066). Linkage analysis in four French families mapped ICCA to 16p12-q12 (3). Based on the paroxysmal nature of these disorders, the co-occurrence of EKD and infantile seizures in some families, and the overlapping map positions, it has been hypothesized that these disorders are allelic. In late 2011, PRRT2, encoding proline-rich transmembrane protein 2, was identified as the gene responsible for EKD1 by whole exome sequencing in eight Han Chinese families (4). Concurrently, Wang and colleagues reported truncating PRRT2 mutations in five EKD1 families, including two large pedigrees with co-occurring EKD and infantile seizures (5). In early 2012, Heron and colleagues reported PRRT2 mutations in a number of ICCA families, as well as families with BFIS only (6). They identified PRRT2 mutations in 14 of 17 BFIS families (82%) and in 5 of 6 ICCA families (83%). Together, these studies provided evidence that EKD1, ICCA, and BFIS2 are, in fact, allelic. PRRT2 is a four-exon gene that encodes a 340 amino-acid protein with two transmembrane domains. PRRT2 is widely expressed in the developing and adult central nervous system, with high levels of expression in the cerebral cortex and basal ganglia (4, 6). It has been shown to interact with SNAP25, a presynaptic protein involved in neurotransmitter release (7, 8). Most PRRT2 mutations reported to date are nonsense mutations that result in premature stop codons. Although the exact function of PRRT2 is unknown, determining the mechanistic basis of PRRT2 mutations may provide new insights into the pathogenesis of infantile epilepsy. In the present study, Ono and colleagues examined 17 Japanese families, including 7 families with EKD only, 2 families with BFIS only, and 8 ICCA families. Overall, this included 68 PKD patients and 13 patients with infantile seizures. To screen for PRRT2 mutations in the patient samples, they performed PCR amplification and Sanger sequencing of PRRT2 exons. In 16 of 17 families (94%), they observed a common mutation, c.649dupC which results in the frameshift mutation p.R217PfsX8. Observation of the same mutation in 16 of 17 Japanese families suggested the possibility that c.649dupC Mutations in PRRT2 Responsible for Paroxysmal Kinesigenic Dyskinesias Also Cause Benign Familial Infantile Convulsions [published online ahead of print March 8, 2012].